Viatris Inc (VTRS) stock news · rev $7.27B
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
This VTRS news page leads with what Viatris Inc filed — not a scraped headline mill.
No cached 8-K sentence for VTRS yet. We will not pad this page with generic market recap.
Latest reported VTRS revenue for 2026-06-30 was $7.27B. VTRS currently screens at market cap $10.83B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the VTRS stock page; for the tape open the quote page.
Not investment advice.